Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson’s Disease
Table 2
Effects of sialidase and GM1 ganglioside administration on unilateral substantia nigra pars compacta dopamine neuron cell counts.